Files in This Item:


Title: Audit of state-funded antiviral treatment for chronic hepatitis C in Qatar
Authors: John, A.K.
Al Kaabi, S.
John, A.
Singh, R.
Derbala, M.
Issue Date: 2010
Language: English
Abstract: Hepatitis C virus [HCV] infection is a major public health problem in the Middle East. A database of 400 patients with chronic HCV in Qatar was retrospectively analysed: 242 patients underwent antiviral treatment, of whom 212 [87.6%] were naive to treatment. The response to treatment and the predictors of response were studied. The largest group of patients were of Egyptian origin. The rate of sustained virological response [SVR] varied significantly between patients with HCV genotypes 2 or 3 [79.6%] and genotype 1 [45.6%] and 4 [the predominant genotype] [51.0%]. Multivariate analysis showed that the independent predictors of SVR were age < 45 years, infection with genotypes 2 or 3, low fibrosis score on liver biopsy and naive treatment status
Description: 1121-1127
Keywords: Hepatitis C, Chronic
Retrospective Studies
Medical Audit
Treatment Outcome
Subject: Hepatitis C, Chronic
ISSN: 1020-3397
Other Identifiers:
Appears in Collections:EMRO Journal Articles (EMHJ)

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.